Aug 26, 2018
In today’s show we discuss the August 2018 Therapeutics Today newsletter with Mary Teeling and MaryJo McAvin, Medical Advisors with The National Medicines Information Centre (NMIC) and co-authors of the newsletter.
Today we discuss new recommendations from UK Faculty of Sexual & Reproductive Health (FSRH) on contraceptive advice for women on potentially teratogenic drugs, a new Cochrane review showing that Omega-3 fatty acids have little or no effect on cardiovascular disease, and a US multicentre RCT comparing Cardiovascular safety of febuxostat vs. allopurinol.
You can receive the newsletter online at nmic.ie, or by post, by sending your details to email@example.com. You’ll get the most out of these discussions if you have the 2 page newsletter to hand. And as a reminder, I include lots of useful resources in the show notes, including hotlinks to the August 2018 NMIC newsletter discussed today, links to the original journal abstracts, and time stamps so you can jump to the section that interests you.
Please email any feedback and suggestions to firstname.lastname@example.org
Please spread the word to colleagues, subscribe via your podcast player, and leave a rating or written review in iTunes or Apple podcasts – it really helps!
NMIC Therapeutics Today August 2018 Newsletter:
NMIC Management Bulletins:
00:02:01 Contraceptive advice for women on potentially teratogenic drugs
00:06:08 Cardiovascular safety of febuxostat vs. allopurinol
00:10:44 Omega - 3 fatty acids have little or no effect on cardiovascular disease
Feedback and suggestions:
Music courtesy of Boost Music: http://boostmusic.com/